Harbour BioMed Wins NMPA IND Approval for HBM7004
Cambridge, Massachusetts; Rotterdam, Netherlands; and Shanghai, China, August 18, 2026 Harbour BioMed (HKEX: 02142) announced that China’s National Medical...
HBM7004
Advertisement
Harbour BioMed Clears Regulatory Milestone for HBM7004
CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; SHANGHAI, China, June 10, 2026 Harbour BioMed announced that the National Medical Products Administration (NMPA)...
Harbour BioMed Receives FDA IND Clearance for HBM7004 Solid Tumor Trial
CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, May 8, 2026 Harbour BioMed announced that the U.S. Food and Drug...
Advertisement
